AdipoLABs (CEO Seongho Han) will will show the medical hyperthermia equipment 'REMISSION 1℃' that received a manufacturing license from Ministry of Food and Drug Safety (MFDS) on Oct 23, 2015 at the '34th Korea International Medical & Hospital Equipment Show (KIMES 2018)' held from March 15 (Thu) to 18 (Sun) in Seoul COEX."
REMISSION 1 ℃ is a medical hyperthermia equipment developed purely by Korean technology, and it is a medical device that treats cancer that is weak to heat by energizing the deep heat of over 40℃ through applying electric current of 40 MHz high frequency into the inside of body.
A case in which cancer is improved by using a combination of the REMISSION 1℃ with an anticancer drugs or an immunotherapeutic agent has been reported successively in the paper, and so it has been confirming that the combined treatment reduces the side effects of anticancer drugs and immunotherapeutic agents and increases the treatment efficiency. In academic journal of the Korean Society for Therapeutic on Oncology (KSTM) in December, 2017, we can see cases of improvement in pancreatic cancer and breast cancer. The REMISSION 1°C is used as a medical hyperthermia equipment for cancer treatment in university hospitals, cancer nursing hospitals and local hospitals.
As a company that has developed the medical hyperthermia equipment 'REMISSION 1 ℃' based on data that has been developed the high frequency medical devices for the cure of obesity and the mitigation of pain, AdipoLABs is a specialized manufacturer of medical equipment that have developed many high-frequency medical devices, including REMISION 1°C.
Meanwhile, KIMES 2018 is the biggest international medical and hospital equipment exhibition of Korea. KIMES sets the stage for introduction of latest tools and technology that may aid in the healthcare industry etc. in the Hospitals and Medical Equipments industry.
→ Go to 'KIMES 2018' News Page